Euronanomed III - Euronanomed III
Targeting breast tumors with anti-Netrin-1 nanocarriers as a promoter of immunity ? – NanoNET
Project coordination
Patrick MEHLEN (Centre de Recherche en Cancérologie de Lyon)
The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.
Partner
CRCL Centre de Recherche en Cancérologie de Lyon
Academia Sinica
Istituto Oncologico Veneto IOV-IRCCS
NETRIS PHARMA
Help of the ANR 264,448 euros
Beginning and duration of the scientific project:
March 2020
- 36 Months
